White papers Zoom Biotech LLC

GLP-1 receptor agonists have redefined the treatment of diabetes, obesity, and metabolic disease. They are, without question, one of the most successful therapeutic classes ever developed. But there is a catch: every one of the leading products requires an injection. For many patients, that’s where the story ends.